# Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients

> **NCT07317154** · PHASE1 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 9 (estimated)

## Conditions studied

- Recurrent Respiratory Papillomatosis

## Interventions

- **BIOLOGICAL:** Autologous HPV6 E6-and E7-derived peptide-loaded dendritic cell

## Key facts

- **NCT ID:** NCT07317154
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-11
- **Final completion:** 2027-02
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07317154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07317154, "Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07317154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*